{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:49Z","timestamp":1787004829670,"version":"build-2736575974"},"reference-count":206,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1053\/j.seminhematol.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T21:43:15Z","timestamp":1705959795000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The molecular map of CLL and Richter's syndrome"],"prefix":"10.1053","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-0164","authenticated-orcid":false,"given":"Amit","family":"Sud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-9769","authenticated-orcid":false,"given":"Erin M.","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5505","key":"10.1053\/j.seminhematol.2024.01.009_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/255197a0","article-title":"Mutation selection and the natural history of cancer","volume":"255","author":"Cairns","year":"1975","journal-title":"Nature"},{"issue":"4260","key":"10.1053\/j.seminhematol.2024.01.009_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1126\/science.959840","article-title":"The clonal evolution of tumor cell populations","volume":"194","author":"Nowell","year":"1976","journal-title":"Science"},{"issue":"7876","key":"10.1053\/j.seminhematol.2024.01.009_bib0003","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03836-1","article-title":"A body map of somatic mutagenesis in morphologically normal human tissues","volume":"597","author":"Li","year":"2021","journal-title":"Nature"},{"issue":"7876","key":"10.1053\/j.seminhematol.2024.01.009_bib0004","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-021-03822-7","article-title":"The mutational landscape of human somatic and germline cells","volume":"597","author":"Moore","year":"2021","journal-title":"Nature"},{"issue":"7239","key":"10.1053\/j.seminhematol.2024.01.009_bib0005","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"issue":"5405","key":"10.1053\/j.seminhematol.2024.01.009_bib0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0007","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1534\/genetics.105.044677","article-title":"Statistical Analysis of Pathogenicity of Somatic Mutations in Cancer","volume":"173","author":"Greenman","year":"2006","journal-title":"Genetics"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0008","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","article-title":"Universal Patterns of Selection in Cancer and Somatic Tissues","volume":"171","author":"Martincorena","year":"2017","journal-title":"Cell"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0009","doi-asserted-by":"crossref","first-page":"14025","DOI":"10.1073\/pnas.93.24.14025","article-title":"Frequent clones of p53-mutated keratinocytes in normal human skin","volume":"93","author":"Jonason","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0010","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"Mart\u00ednez-Jim\u00e9nez","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0011","doi-asserted-by":"crossref","unstructured":"Kinnersley B, Sud A, Everall A, et al. Cancer driver genes and opportunities for precision oncology revealed by whole genome sequencing 10,478 cancers. bioRxiv. Published online May 25, 2023. 10.1101\/2023.05.24.23289454","DOI":"10.1101\/2023.05.24.23289454"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0012","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive Characterization of Cancer Driver Genes and Mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"issue":"7457","key":"10.1053\/j.seminhematol.2024.01.009_bib0013","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13073-019-0632-z","article-title":"Translating insights into tumor evolution to clinical practice: promises and challenges","volume":"11","author":"Fittall","year":"2019","journal-title":"Genome Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0015","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0016","first-page":"285","article-title":"Generalized Reticular Cell Sarcoma of Lymph Nodes Associated with Lymphatic Leukemia","volume":"4","author":"Richter","year":"1928","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0017","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Matutes","year":"1994","journal-title":"Leukemia"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0018","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41375-023-01852-w","article-title":"Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment","volume":"37","author":"Hemminki","year":"2023","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0019","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1182\/blood-2013-11-516229","article-title":"How we treat Richter syndrome","volume":"123","author":"Parikh","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0020","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41591-022-02113-6","article-title":"Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome","volume":"29","author":"Parry","year":"2023","journal-title":"Nat Med"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.01.009_bib0022","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.2020005650","article-title":"Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia","volume":"137","author":"Klintman","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2643-3230.BCD-22-0082","article-title":"In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities","volume":"4","author":"Ten Hacken","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrc.2017.82","article-title":"Genome-wide association studies of cancer: current insights and future perspectives","volume":"17","author":"Sud","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"7714","key":"10.1053\/j.seminhematol.2024.01.009_bib0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","article-title":"Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations","volume":"559","author":"Loh","year":"2018","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0026","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","article-title":"Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms","volume":"128","author":"Hinds","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0027","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1182\/blood.2019001362","article-title":"Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk","volume":"134","author":"Sud","year":"2019","journal-title":"Blood"},{"issue":"19","key":"10.1053\/j.seminhematol.2024.01.009_bib0028","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2016-01-695692","article-title":"Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia","volume":"128","author":"Speedy","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0029","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1038\/s41467-019-11582-2","article-title":"Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics","volume":"10","author":"Speedy","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1200\/JCO.22.00269","article-title":"Rare Germline Variants Influence the Development of Chronic Lymphocytic Leukemia","volume":"41","author":"Lampson","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng.510","article-title":"Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk","volume":"42","author":"Crowther-Swanepoel","year":"2010","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0032","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2010-09-308205","article-title":"Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL","volume":"117","author":"Slager","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0033","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2012-03-413591","article-title":"Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia","volume":"120","author":"Slager","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0034","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/ng.219","article-title":"A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia","volume":"40","author":"Di Bernardo","year":"2008","journal-title":"Nat Genet"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0035","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ng.2652","article-title":"Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0036","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.2843","article-title":"A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia","volume":"46","author":"Speedy","year":"2014","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0037","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1038\/ncomms10933","article-title":"Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia","volume":"7","author":"Berndt","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0038","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0167-5699(94)90009-4","article-title":"The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire","volume":"15","author":"Schroeder","year":"1994","journal-title":"Immunol Today"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0039","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0041","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood.V89.11.4153","article-title":"Differential rates of somatic hypermutation in VH genes among subsets of Chronic Lymphocytic leukemia defined by chromosomal abnormalities","volume":"89","author":"Oscier","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0042","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0043","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM198402023100504","article-title":"Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia","volume":"310","author":"Han","year":"1984","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.009_bib0044","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM199009133231105","article-title":"Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities","volume":"323","author":"Juliusson","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0046","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2141.1984.tb06112.x","article-title":"Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia","volume":"58","author":"Pittman","year":"1984","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0047","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1053\/j.seminhematol.2024.01.009_bib0048","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1073\/pnas.93.21.11837","article-title":"Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders","volume":"93","author":"Stilgenbauer","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0049","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1073\/pnas.83.1.130","article-title":"The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)","volume":"83","author":"McBride","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0050","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","article-title":"A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation","volume":"146","author":"Di Ianni","year":"2009","journal-title":"Br J Haematol"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0051","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9146","key":"10.1053\/j.seminhematol.2024.01.009_bib0052","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(98)10117-4","article-title":"Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia","volume":"353","author":"Stankovic","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0053","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V85.6.1580.bloodjournal8561580","article-title":"p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias","volume":"85","author":"D\u00f6hner","year":"1995","journal-title":"Blood"},{"issue":"7354","key":"10.1053\/j.seminhematol.2024.01.009_bib0054","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat Genet"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.009_bib0056","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0057","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0058","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ng.2584","article-title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia","volume":"45","author":"Ramsay","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0059","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"issue":"7574","key":"10.1053\/j.seminhematol.2024.01.009_bib0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"7574","key":"10.1053\/j.seminhematol.2024.01.009_bib0061","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0062","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0063","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41588-022-01211-y","article-title":"Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features","volume":"54","author":"Robbe","year":"2022","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0064","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1038\/ncomms9866","article-title":"Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution","volume":"6","author":"Kasar","year":"2015","journal-title":"Nat Commun"},{"issue":"5910","key":"10.1053\/j.seminhematol.2024.01.009_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1126\/science.1162986","article-title":"Real-time DNA sequencing from single polymerase molecules","volume":"323","author":"Eid","year":"2009","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0066","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/2047-217X-3-22","article-title":"A reference bacterial genome dataset generated on the MinIONTM portable single-molecule nanopore sequencer","volume":"3","author":"Quick","year":"2014","journal-title":"Gigascience"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0067","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cell.2015.05.048","article-title":"Mapping Nucleosome Resolution Chromosome Folding in Yeast by Micro-C","volume":"162","author":"Hsieh","year":"2015","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0068","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"issue":"1-2","key":"10.1053\/j.seminhematol.2024.01.009_bib0069","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2018.11.029","article-title":"A Genome-wide Framework for Mapping Gene Regulation via Cellular Genetic Screens","volume":"176","author":"Gasperini","year":"2019","journal-title":"Cell"},{"issue":"7463","key":"10.1053\/j.seminhematol.2024.01.009_bib0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0071","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3324\/haematol.2020.265777","article-title":"Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy","volume":"107","author":"Zapatka","year":"2022","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0072","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3324\/haematol.2019.217307","article-title":"Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription","volume":"105","author":"Edelmann","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0073","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2016-06-719294","article-title":"Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia","volume":"129","author":"Ahn","year":"2017","journal-title":"Blood"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.01.009_bib0074","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1182\/blood-2016-05-716977","article-title":"Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience","volume":"128","author":"Mato","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.01.009_bib0075","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2014-09-603670","article-title":"Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib","volume":"125","author":"Jain","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0076","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/jamaoncol.2014.218","article-title":"Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia","volume":"1","author":"Maddocks","year":"2015","journal-title":"JAMA Oncol"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0077","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib","volume":"370","author":"Woyach","year":"2014","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0078","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1056\/NEJMc1402716","article-title":"Ibrutinib resistance in chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.01.009_bib0079","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1200\/JCO.2016.70.2282","article-title":"BTK-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia","volume":"35","author":"Woyach","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0080","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-017-02329-y","article-title":"The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy","volume":"8","author":"Landau","year":"2017","journal-title":"Nat Commun"},{"issue":"Supplement_1","key":"10.1053\/j.seminhematol.2024.01.009_bib0081","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2019-125488","article-title":"BTK Leu528Trp - a potential secondary resistance mechanism specific for patients with chronic Lymphocytic leukemia treated with the next generation BTK inhibitor zanubrutinib","volume":"134","author":"Handunnetti","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0082","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa2114110","article-title":"Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors","volume":"386","author":"Wang","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0083","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/2159-8290.CD-18-1119","article-title":"Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia","volume":"9","author":"Blombery","year":"2019","journal-title":"Cancer Discov"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0084","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1182\/blood.2019003722","article-title":"Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK\/PLCG2 mutations","volume":"135","author":"Lucas","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0085","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1182\/blood.2019004205","article-title":"Multiple BCL2 mutations cooccurring with Gly101Val emerge in chronic lymphocytic leukemia progression on venetoclax","volume":"135","author":"Blombery","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0086","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.08.005","article-title":"Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies","volume":"36","author":"Gui\u00e8ze","year":"2019","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0087","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.2022016600","article-title":"Genetic events associated with venetoclax resistance in CLL identified by whole-exome sequencing of patient samples","volume":"142","author":"Khalsa","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0088","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0089","first-page":"673","article-title":"A study of ras gene mutations in colonic adenomas from familial polyposis coli patients","volume":"3","author":"Farr","year":"1988","journal-title":"Oncogene"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0090","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The life history of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"issue":"7793","key":"10.1053\/j.seminhematol.2024.01.009_bib0091","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","article-title":"The evolutionary history of 2,658 cancers","volume":"578","author":"Gerstung","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a026625","article-title":"Principles of Reconstructing the Subclonal Architecture of Cancers","volume":"7","author":"Dentro","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7762","key":"10.1053\/j.seminhematol.2024.01.009_bib0093","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0094","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","article-title":"An integrated cell atlas of the lung in health and disease","volume":"29","author":"Sikkema","year":"2023","journal-title":"Nat Med"},{"issue":"6594","key":"10.1053\/j.seminhematol.2024.01.009_bib0095","doi-asserted-by":"crossref","first-page":"eabl4290","DOI":"10.1126\/science.abl4290","article-title":"Single-nucleus cross-tissue molecular reference maps toward understanding disease gene function","volume":"376","author":"Eraslan","year":"2022","journal-title":"Science"},{"issue":"6237","key":"10.1053\/j.seminhematol.2024.01.009_bib0096","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1126\/science.aab1601","article-title":"Multiplex single cell profiling of chromatin accessibility by combinatorial cellular indexing","volume":"348","author":"Cusanovich","year":"2015","journal-title":"Science"},{"issue":"6256","key":"10.1053\/j.seminhematol.2024.01.009_bib0097","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.aab1785","article-title":"Somatic mutation in single human neurons tracks developmental and transcriptional history","volume":"350","author":"Lodato","year":"2015","journal-title":"Science"},{"issue":"7469","key":"10.1053\/j.seminhematol.2024.01.009_bib0098","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature12593","article-title":"Single-cell Hi-C reveals cell-to-cell variability in chromosome structure","volume":"502","author":"Nagano","year":"2013","journal-title":"Nature"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0099","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nbt.2938","article-title":"Linking T-cell receptor sequence to functional phenotype at the single-cell level","volume":"32","author":"Han","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"7341","key":"10.1053\/j.seminhematol.2024.01.009_bib0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature09807","article-title":"Tumour evolution inferred by single-cell sequencing","volume":"472","author":"Navin","year":"2011","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0101","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt.3383","article-title":"Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state","volume":"33","author":"Rotem","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0102","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat Methods"},{"issue":"6190","key":"10.1053\/j.seminhematol.2024.01.009_bib0103","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"issue":"6282","key":"10.1053\/j.seminhematol.2024.01.009_bib0104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","article-title":"Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq","volume":"352","author":"Tirosh","year":"2016","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0105","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0106","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0107","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0108","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0109","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gr.217331.116","article-title":"Integrated single-cell genetic and transcriptional analysis suggests novel drivers of chronic lymphocytic leukemia","volume":"27","author":"Wang","year":"2017","journal-title":"Genome Res"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0110","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"7757","key":"10.1053\/j.seminhematol.2024.01.009_bib0111","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1198-z","article-title":"Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia","volume":"569","author":"Gaiti","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2643-3230.BCD-19-0058","article-title":"Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and Therapy","volume":"2","author":"Kretzmer","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-019-14081-6","article-title":"Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL","volume":"11","author":"Rendeiro","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0114","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/2159-8290.CD-21-0276","article-title":"Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History","volume":"11","author":"Penter","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0115","article-title":"Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics","volume":"12","author":"Penter","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0116","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2010.09.016","article-title":"Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells","volume":"143","author":"Snippert","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0117","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ccr.2011.04.019","article-title":"Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung","volume":"19","author":"Sutherland","year":"2011","journal-title":"Cancer Cell"},{"issue":"7222","key":"10.1053\/j.seminhematol.2024.01.009_bib0118","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature07567","article-title":"Efficient tumour formation by single human melanoma cells","volume":"456","author":"Quintana","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0119","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm.3841","article-title":"Studying clonal dynamics in response to cancer therapy using high-complexity barcoding","volume":"21","author":"Bhang","year":"2015","journal-title":"Nat Med"},{"issue":"7539","key":"10.1053\/j.seminhematol.2024.01.009_bib0120","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature13952","article-title":"Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution","volume":"518","author":"Eirew","year":"2015","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0121","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1038\/ncomms6871","article-title":"DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts","volume":"5","author":"Nguyen","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0122","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41467-019-09203-z","article-title":"Lineage tracing using a Cas9-deaminase barcoding system targeting endogenous L1 elements","volume":"10","author":"Hwang","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0123","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41587-020-0645-6","article-title":"Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling","volume":"39","author":"Lareau","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0124","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0125","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"issue":"7765","key":"10.1053\/j.seminhematol.2024.01.009_bib0126","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-019-1367-0","article-title":"Somatic mutations and cell identity linked by Genotyping of Transcriptomes","volume":"571","author":"Nam","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0127","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13059-021-02525-6","article-title":"Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing","volume":"22","author":"Tian","year":"2021","journal-title":"Genome Biol"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.01.009_bib0128","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2022016040","article-title":"Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy","volume":"140","author":"Thijssen","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0129","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/2159-8290.CD-14-0104","article-title":"Acquired initiating mutations in early hematopoietic cells of CLL patients","volume":"4","author":"Damm","year":"2014","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0131","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s43018-021-00222-8","article-title":"Multifunctional barcoding with ClonMapper enables high-resolution study of clonal dynamics during tumor evolution and treatment","volume":"2","author":"Gutierrez","year":"2021","journal-title":"Nat Cancer"},{"issue":"561","key":"10.1053\/j.seminhematol.2024.01.009_bib0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abb7661","article-title":"Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect","volume":"12","author":"Bachireddy","year":"2020","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0133","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41375-020-0714-3","article-title":"CRISPR\/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition","volume":"34","author":"Quijada-\u00c1lamo","year":"2020","journal-title":"Leukemia"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-10-604959","article-title":"Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia","volume":"126","author":"Rodr\u00edguez","year":"2015","journal-title":"Blood"},{"issue":"22","key":"10.1053\/j.seminhematol.2024.01.009_bib0135","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2017-09-804401","article-title":"Altered patterns of global protein synthesis and translational fidelity in RPS15-mutated chronic lymphocytic leukemia","volume":"132","author":"Bretones","year":"2018","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108845","article-title":"Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patients","volume":"34","author":"Reid","year":"2021","journal-title":"Cell Rep"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0137","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/blood-2005-12-5148","article-title":"Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia","volume":"108","author":"Kojima","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0138","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3324\/haematol.2019.219550","article-title":"Biological and clinical implications of mutations in chronic lymphocytic leukemia","volume":"105","author":"Diop","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0139","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/leu.2014.318","article-title":"The impact of SF3B1 mutations in CLL on the DNA-damage response","volume":"29","author":"Te Raa","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1182\/blood-2015-05-644872","article-title":"ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells","volume":"127","author":"Kwok","year":"2016","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0141","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2018.01.021","article-title":"Systematic Functional Annotation of Somatic Mutations in Cancer","volume":"33","author":"Ng","year":"2018","journal-title":"Cancer Cell"},{"issue":"25","key":"10.1053\/j.seminhematol.2024.01.009_bib0142","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood.2021011993","article-title":"Understanding CLL biology through mouse models of human genetics","volume":"138","author":"Ten Hacken","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0143","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood.V82.10.3141.3141","article-title":"Common clonal origin of chronic lymphocytic leukemia and high-grade lymphoma of Richter's syndrome","volume":"82","author":"Cherepakhin","year":"1993","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0144","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1182\/blood.V83.5.1363.1363","article-title":"Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma)","volume":"83","author":"Matolcsy","year":"1994","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0146","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1084\/jem.20131448","article-title":"Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome","volume":"210","author":"Fabbri","year":"2013","journal-title":"J Exp Med"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2024.01.009_bib0147","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood-2018-99-112442","article-title":"Risk factors associated with richter's transformation in patients with chronic Lymphocytic leukemia","volume":"132","author":"Ben-Dali","year":"2018","journal-title":"Blood"},{"issue":"15","key":"10.1053\/j.seminhematol.2024.01.009_bib0148","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0149","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.01.009_bib0150","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-08-3266","article-title":"Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0151","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3324\/haematol.2021.278304","article-title":"The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation","volume":"107","author":"Visentin","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0152","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.932","article-title":"Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas","volume":"28","author":"Scandurra","year":"2010","journal-title":"Hematol Oncol"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0153","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood.2020008276","article-title":"B-cell receptor signaling and genetic lesions in TP53 and CDKN2A\/CDKN2B cooperate in Richter transformation","volume":"138","author":"Chakraborty","year":"2021","journal-title":"Blood"},{"issue":"25","key":"10.1053\/j.seminhematol.2024.01.009_bib0154","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2017-01-763003","article-title":"Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax","volume":"129","author":"Anderson","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0155","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41467-018-03170-7","article-title":"Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia","volume":"9","author":"Herling","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0156","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/leu.2012.357","article-title":"NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome","volume":"27","author":"Villamor","year":"2013","journal-title":"Leukemia"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0157","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3109\/10428194.2012.723706","article-title":"MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia","volume":"54","author":"De Paoli","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0158","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09155.x","article-title":"Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome","volume":"158","author":"Rossi","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0159","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1038\/ncomms14756","article-title":"Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia","volume":"8","author":"Yeh","year":"2017","journal-title":"Nat Commun"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.009_bib0160","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","article-title":"Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL","volume":"129","author":"Ding","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0161","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1182\/blood-2014-12-610782","article-title":"The efficacy of ibrutinib in the treatment of Richter syndrome","volume":"125","author":"Tsang","year":"2015","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2024.01.009_bib0162","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/blood-2018-99-117526","article-title":"Phase I\/II study of umbralisib (TGR-1202) in combination with ublituximab (TG-1101) and pembrolizumab in patients with relapsed\/refractory CLL and Richter's Transformation","volume":"132","author":"Mato","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0163","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1200\/JCO.2016.70.4320","article-title":"Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma","volume":"35","author":"Davids","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0164","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41375-022-01758-z","article-title":"VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia","volume":"37","author":"Sher","year":"2023","journal-title":"Leukemia"},{"issue":"18","key":"10.1053\/j.seminhematol.2024.01.009_bib0165","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1200\/JCO.20.03175","article-title":"Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial","volume":"39","author":"Hutchings","year":"2021","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.01.009_bib0166","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood.2020008404","article-title":"ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models","volume":"137","author":"Vaisitti","year":"2021","journal-title":"Blood"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.009_bib0167","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/JCO.2017.72.8519","article-title":"Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib","volume":"35","author":"Turtle","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6233","key":"10.1053\/j.seminhematol.2024.01.009_bib0168","doi-asserted-by":"crossref","first-page":"aaa6090","DOI":"10.1126\/science.aaa6090","article-title":"RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells","volume":"348","author":"Chen","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0169","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0170","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41587-020-0739-1","article-title":"Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2","volume":"39","author":"Stickels","year":"2021","journal-title":"Nat Biotechnol"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0171","doi-asserted-by":"crossref","unstructured":"Russell AJC, Weir JA, Nadaf NM, et al. Slide-tags: scalable, single-nucleus barcoding for multi-modal spatial genomics. bioRxiv. Published online April 3, 2023. 10.1101\/2023.04.01.535228","DOI":"10.1101\/2023.04.01.535228"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.01.009_bib0172","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.immuni.2022.09.002","article-title":"Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response","volume":"55","author":"Liu","year":"2022","journal-title":"Immunity"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0173","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","article-title":"Spatial biology of cancer evolution","volume":"24","author":"Seferbekova","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.01.009_bib0174","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccell.2018.12.013","article-title":"A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion","volume":"35","author":"Yin","year":"2019","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1053\/j.seminhematol.2024.01.009_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI163325","article-title":"SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation","volume":"133","author":"Cusan","year":"2023","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0176","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/s41588-023-01460-5","article-title":"SF3B1 hotspot mutations confer sensitivity to PARP inhibition by eliciting a defective replication stress response","volume":"55","author":"Bland","year":"2023","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0177","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41467-020-15171-6","article-title":"Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns","volume":"11","author":"Tang","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0178","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/leu.2013.319","article-title":"Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia","volume":"28","author":"Arruga","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0179","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/leu.2016.383","article-title":"Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22","volume":"31","author":"Arruga","year":"2017","journal-title":"Leukemia"},{"issue":"26","key":"10.1053\/j.seminhematol.2024.01.009_bib0180","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2014-01-552307","article-title":"Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations","volume":"123","author":"Riches","year":"2014","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.01.009_bib0181","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/leu.2017.90","article-title":"NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components","volume":"31","author":"Pozzo","year":"2017","journal-title":"Leukemia"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0182","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/leu.2017.296","article-title":"NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-\u03baB pathways","volume":"32","author":"Benedetti","year":"2018","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0183","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1182\/blood-2006-09-046698","article-title":"Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation","volume":"109","author":"Thomas","year":"2007","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0184","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1038\/bcj.2016.69","article-title":"ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)","volume":"6","author":"Jiang","year":"2016","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0185","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.leu.2405092","article-title":"A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL","volume":"22","author":"Best","year":"2008","journal-title":"Leukemia"},{"issue":"34","key":"10.1053\/j.seminhematol.2024.01.009_bib0186","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1200\/JCO.2007.11.2649","article-title":"Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion","volume":"25","author":"Austen","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0187","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41467-017-00210-6","article-title":"Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia","volume":"8","author":"Knittel","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0188","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.V99.1.300","article-title":"Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage","volume":"99","author":"Stankovic","year":"2002","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0189","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3324\/haematol.2011.048827","article-title":"ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele","volume":"97","author":"Skowronska","year":"2012","journal-title":"Haematologica"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a026070","article-title":"p53 in the DNA-Damage-Repair Process","volume":"6","author":"Williams","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0191","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1182\/blood-2003-04-1161","article-title":"Microarray analysis reveals that TP53- and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses","volume":"103","author":"Stankovic","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0192","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V98.3.814","article-title":"p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation","volume":"98","author":"Pettitt","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2024.01.009_bib0193","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41556-018-0084-5","article-title":"Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2","volume":"20","author":"Choi","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.01.009_bib0194","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13045-021-01032-2","article-title":"Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia","volume":"14","author":"Walker","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0195","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2024.01.009_bib0196","doi-asserted-by":"crossref","unstructured":"Iyer P, Zhang B, Liu T, et al. deletion leads to Richter's transformation via modulation of mitochondrial OXPHOS. bioRxiv. Published online February 8, 2023. 10.1101\/2023.02.07.527502","DOI":"10.1101\/2023.02.07.527502"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2024.01.009_bib0197","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood-2023-188872","article-title":"Loss of DDX3X function promotes CLL progression by facilitating NOTCH1 mRNA translation","volume":"142","author":"Miao","year":"2023","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.seminhematol.2024.01.009_bib0198","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.molmed.2023.06.003","article-title":"The variant landscape and function of DDX3X in cancer and neurodevelopmental disorders","volume":"29","author":"Gadek","year":"2023","journal-title":"Trends Mol Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.01.009_bib0199","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1182\/blood-2015-10-674572","article-title":"Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations","volume":"127","author":"Ljungstr\u00f6m","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.01.009_bib0200","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1182\/bloodadvances.2020001717","article-title":"RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia","volume":"5","author":"Ntoufa","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0201","doi-asserted-by":"crossref","first-page":"637","DOI":"10.21147\/j.issn.1000-9604.2021.06.01","article-title":"ZNF292 suppresses proliferation of ESCC cells through ZNF292\/SKP2\/P27 signaling axis","volume":"33","author":"Gong","year":"2021","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.01.009_bib0202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20202001","article-title":"Human marginal zone B cell development from early T2 progenitors","volume":"218","author":"Tull","year":"2021","journal-title":"J Exp Med"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.01.009_bib0203","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.immuni.2007.02.010","article-title":"Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits","volume":"26","author":"Thompson","year":"2007","journal-title":"Immunity"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.01.009_bib0204","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/ni.1676","article-title":"Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK","volume":"9","author":"Zarnegar","year":"2008","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.01.009_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-021-00520-5","article-title":"Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression","volume":"11","author":"Quijada-\u00c1lamo","year":"2021","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.01.009_bib0206","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1158\/1078-0432.CCR-18-1548","article-title":"BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-\u03baB Nuclear Translocation","volume":"25","author":"Asslaber","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719632400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003719632400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T16:54:52Z","timestamp":1731084892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003719632400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":206,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S003719632400009X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.009","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular map of CLL and Richter's syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}